CRA was retained by counsel for the Plaintiff in a patent infringement suit involving an antiemetic agent for the prevention of chemotherapy-induced nausea and vomiting as well as acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic chemotherapy. CRA prepared an expert report and provided trial testimony demonstrating commercial success, ultimately leading to a successful outcome and a ruling that that the subject patents were not invalid.
Representations and warranties insurance
Insurance for mergers and acquisitions has grown significantly over the last several years as it allows buyers and sellers to share the transaction risk with a...